1. Metadherin: A Therapeutic Target in Multiple Cancers
   Gourav Dhiman et al, 2019, Front. Oncol. CrossRef
2. Metadherin Expression is Associated with Extrathyroidal Extension in Papillary Thyroid Cancer Patients
   Robert F. Moore et al, 2016, Ann Surg Oncol CrossRef
3. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis
   Yuxiong Liu et al, 2020, Thorac Cancer CrossRef
4. Metadherin overexpression in perihilar cholangiocarcinoma is associated with lymph node metastasis and poor prognosis
   Yan‑Zhi Zhu et al, 2019, Oncol Lett CrossRef
5. MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
   Danxia Cao et al, 2020, Biol Res CrossRef
6. Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
   Mohammad Hasan Soheilifar et al, 2021, Journal of Advanced Research CrossRef
7. MicroRNAs: An Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
   Bashdar Mahmud Hussen et al, 2021, Front. Mol. Biosci. CrossRef
8. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
   Luying He et al, 2022, Front. Pharmacol. CrossRef
9. Ehrlich Ascites carcinoma mice model for studying liver inflammation and fibrosis
   Nirmala G. Sannappa Gowda et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
10. null
    Muhammad T. Abdel Ghafar et al, 2022 CrossRef
11. METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
    Ying Huang et al, 2022, Biomark Res CrossRef
12. The Proteome Landscape of Human Placentas for Monochorionic Twins with Selective Intrauterine Growth Restriction
    Xin-Lu Meng et al, 2023, Genomics, Proteomics & Bioinformatics CrossRef